Chorionic Gonadotrophin for injection

Short Description:

Indications

1. Diagnosis and treatment of prepubertal cryptorchidism.

2. Male infertility caused by hypopituitarism can be combined with urogonadotropin. Long-term hypogonadotropin function. It should also be supplemented with testosterone therapy.

3. Anovulatory infertility in women caused by pituitary gonadotropin insufficiency is often combined with urogonadotrophin to promote ovulation after clomiphene treatment is ineffective.

4. Used for in vitro fertilization to obtain multiple oocytes, in combination with menotrophin.

5. Treatment of luteal insufficiency in women.

6. Functional uterine bleeding, threatened miscarriage in the first trimester, recurrent miscarriage.

Send email to us

Product Detail

Product Tags

Specification

Chorionic Gonadotrophin for injection
Source		Pregnant woman urine
Definition		This product is a freeze-dried sterile product with chorionic gonadotrophin plus suitable excipients. Its titer should be 80%~125% of the labeled amount	Chorionic Gonadotrophin for Injection is a sterile material consisting of Chorionic Gonadotrophin with or without excipients. It is supplied in a sealedcontainer
Pharmacopoeia standard		CP	BP
Character		This product is a white lyophilized block or powder.	A white or almost white, amorphous powder
Identification		_______	Causes an increase in the weight of the seminal vesicles or the prostate glands of immature male rats when administered as directed under the Assay.
Test	Loss on drying	≤5.0%	_______
	Abnormal toxicity	Conform with regulation
	Bacterial endotoxin	＜0.01EU/IU	The endotoxin limit concentration of solution A is 15 IU of endotoxin per mL
	Acidity or alkalinity	_______	pH of a 1% w/v solution, 6.0 to 8.0
	Clarity and colour of solution	_______	Solution is clear and colourless
	Content uniformity	±15%	_______
	Visible foreign matter	Conform with regulation	_______
	Sterile	Conform with regulation	_______
Potency		80%～125% of the stated potency	80%～125% of the stated potency
Storage		Sealed and kept in a cool dark place.	The sealed container should be protected from light and stored at a temperature not exceeding 20℃.
Category		Gonadotropin drugs
Specification		1000 units 5000units

1000 units 5000units

Contraindication

Patients suspected of having pituitary hyperplasia or swelling and pain, prostate cancer or other androgen-related swelling and pain tumors are contraindicated (with promoting effect). Patients with precocious puberty, vaginal bleeding with an undiagnosed diagnosis, subordinate fibroids, ovarian cysts or ovarian enlargement, thrombophlebitis, and patients with a history of allergy to gonadal stimulating hormones are contraindicated.

Notice

1. It should be used with caution in the following conditions: enlarged prostate, asthma, epilepsy, heart disease, migraine, renal impairment, etc.
2. If ovarian hyperstimulation syndrome and ovarian enlargement, pleural effusion, ascites and other comorbidities are found, the drug should be discontinued or seek medical advice.
3. The possibility of multiple pregnancies should be communicated to the patient before use. Ask about adverse reactions during use and conduct relevant clinical examinations regularly.
4. Pregnancy tests can be falsely positive and should be tested 10 days after administration.
5. Use with caution in patients with hypertension.
6. This product is temporarily formulated before application.

Previous: Chorionic Gonadotrophin
CAS No.: 9002-61-3 (Gonadotrophic hormone)

Next: Urokinase for injection

Write your message here and send it to us

Products categories

Urokinase for injection